Post by
CADInvestor12 on Jun 13, 2024 12:21pm
Recent Posts
I would read this board to try and get other investors opinions on earnings/ developments etc. Some have interesting perspectives, while others are completely clueless. I'm surprised with the recent opinions, frankly it proves that most of you have no idea what you're talking about. Yes, the share price is frustrating and the longer term growth catalysts are taking longer than expected but how can you not be impressed with the current exec team? The business has completely turned around, when Pidduck started TTM revenue was ~$21.1M & losing ~$48M (Q1/22 to Q2/21). Now TTM revenue is ~$37M & losing ~$13M and we're on the cusp of positive EBITDA + cash flow. Over the last 2 years revenue has almost doubled, while savings of ~$35M have been realized. With Medipharms existing infrastructure any M&A deal (even if they use equity) would be accretive and would create more value/ a better use of cash than a share buyback. For those spewing garbage about managements poor performance & advocating buybacks, give your head a shake and go invest in mutual funds. You don't belong here and have no idea what it takes to successfully grow/ turn a business around.
Comment by
QContinuum1 on Jun 13, 2024 7:32pm
The reason I say buyback now is because of the claim that they are at the cusp of CFP. So keep the enemies at the gate for now and wait a few more quarters before going carcass hunting. They'll still be there when we're ready and if they're not, so be it, wasn't meant to be. But certainly I'm ok with M&A, just not now.